Total Payments
$2,337
2024 Payments
$352.17
Companies
22
Transactions
88
Medicare Patients
1,734
Medicare Billing
$122,697
Payment Breakdown by Category
Food & Beverage$2,257 (96.6%)
Education$79.99 (3.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,257 | 87 | 96.6% |
| Education | $79.99 | 1 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merz North America, Inc. | $404.23 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $331.39 | 16 | $0 (2024) |
| Medtronic Vascular, Inc. | $254.49 | 9 | $0 (2020) |
| Janssen Biotech, Inc. | $222.73 | 6 | $0 (2023) |
| Abbott Laboratories | $170.93 | 2 | $0 (2018) |
| PFIZER INC. | $134.94 | 7 | $0 (2024) |
| Galderma Laboratories, L.P. | $126.94 | 8 | $0 (2024) |
| Amgen Inc. | $114.89 | 6 | $0 (2019) |
| LEO Pharma Inc. | $111.94 | 5 | $0 (2024) |
| AbbVie, Inc. | $75.68 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $352.17 | 15 | LEO Pharma Inc. ($92.47) |
| 2023 | $410.07 | 17 | Janssen Biotech, Inc. ($194.29) |
| 2022 | $410.80 | 9 | Merz North America, Inc. ($247.52) |
| 2021 | $182.35 | 4 | MERZ NORTH AMERICA, INC. ($136.87) |
| 2020 | $13.56 | 1 | Medtronic Vascular, Inc. ($13.56) |
| 2019 | $316.11 | 16 | Amgen Inc. ($91.84) |
| 2018 | $398.16 | 12 | Abbott Laboratories ($170.93) |
| 2017 | $253.83 | 14 | Novartis Pharmaceuticals Corporation ($75.55) |
All Payment Transactions
88 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Organogenesis Inc. | PURAPLY WOUND MATRIX (Device) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: WOUND CARE | ||||||
| 10/21/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: Inflammation & Immunology | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: Dermatology | ||||||
| 08/21/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Inflammation & Immunology | ||||||
| 08/07/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: DERMATOLOGY | ||||||
| 06/03/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: DERMATOLOGY | ||||||
| 05/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: IMMUNOLOGY | ||||||
| 05/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.36 | General |
| Category: Immunology | ||||||
| 03/18/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $22.06 | General |
| 02/21/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: DERMATOLOGY | ||||||
| 02/12/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: DERMATOLOGY | ||||||
| 01/29/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: Dermatology | ||||||
| 01/22/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: DERMATOLOGY | ||||||
| 01/16/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $18.08 | General |
| 10/19/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $17.01 | General |
| 10/09/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.42 | General |
| Category: Immunology | ||||||
| 09/08/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: Immunology | ||||||
| 08/31/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.61 | General |
| Category: Immunology | ||||||
| 08/17/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $22.12 | General |
| 08/07/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $79.99 | General |
| Category: Immunology | ||||||
| 07/10/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: DERMATOLOGY | ||||||
| 07/06/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: Immunology | ||||||
| 06/27/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 390 | 662 | $88,470 | $28,277 |
| 2022 | 10 | 461 | 937 | $116,190 | $34,945 |
| 2021 | 10 | 467 | 916 | $115,140 | $35,873 |
| 2020 | 10 | 416 | 775 | $87,325 | $23,602 |
Total Patients
1,734
Total Services
3,290
Medicare Billing
$122,697
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 156 | 191 | $33,425 | $12,985 | 38.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 66 | 83 | $18,675 | $4,027 | 21.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 32 | 38 | $11,020 | $3,151 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 27 | $6,075 | $2,410 | 39.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $5,400 | $1,903 | 35.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $4,225 | $1,570 | 37.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 42 | 226 | $5,650 | $1,269 | 22.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 20 | $3,000 | $929.29 | 31.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 40 | $1,000 | $32.90 | 3.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 151 | 199 | $34,825 | $14,222 | 40.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 72 | 101 | $22,725 | $4,432 | 19.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 42 | 56 | $16,240 | $4,399 | 27.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 47 | 47 | $10,575 | $3,761 | 35.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 51 | 378 | $9,450 | $2,117 | 22.4% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2022 | 13 | 37 | $7,400 | $1,769 | 23.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 37 | 40 | $6,000 | $1,638 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 14 | $3,150 | $1,370 | 43.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 13 | 14 | $4,550 | $1,197 | 26.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 22 | 51 | $1,275 | $40.19 | 3.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 169 | 220 | $38,500 | $15,584 | 40.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 53 | 66 | $19,140 | $5,300 | 27.7% |
| 17000 | Destruction of skin growth | Office | 2021 | 75 | 104 | $23,400 | $4,806 | 20.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 32 | 32 | $7,200 | $2,514 | 34.9% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 48 | 366 | $9,150 | $2,105 | 23.0% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 12 | 15 | $4,875 | $2,022 | 41.5% |
About Dr. Ivan Cohen, MD
Dr. Ivan Cohen, MD is a Dermatology healthcare provider based in Fairfield, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851488191.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ivan Cohen, MD has received a total of $2,337 in payments from pharmaceutical and medical device companies, with $352.17 received in 2024. These payments were reported across 88 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,257).
As a Medicare-enrolled provider, Cohen has provided services to 1,734 Medicare beneficiaries, totaling 3,290 services with total Medicare billing of $122,697. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Fairfield, CT
- Active Since 10/06/2006
- Last Updated 07/08/2007
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1851488191
Products in Payments
- TREMFYA (Drug) $222.73
- ClosureFast (Device) $207.79
- COSENTYX (Biological) $192.92
- Proclaim Family of SCS IPGs (Device) $170.93
- Enbrel (Biological) $114.89
- COSENTYX (Drug) $113.63
- ADBRY (Biological) $111.94
- EUCRISA (Drug) $81.20
- Humira (Biological) $75.68
- VenaSeal (Device) $64.38
- Ameluz (Drug) $57.37
- CIBINQO (Drug) $53.74
- VTAMA (Drug) $41.91
- Impoyz (Drug) $35.78
- BOTOX COSMETIC (Biological) $34.27
- DUPIXENT (Biological) $29.28
- PURAPLY WOUND MATRIX (Device) $26.53
- DSUVIA (Drug) $26.45
- BOTOX (Biological) $26.21
- XOLAIR (Drug) $24.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Fairfield
Dr. Brett King, Md, MD
Dermatology — Payments: $2.5M
Dermatology $2.5M
Dr. Elizabeth Smith, M.d, M.D
Dermatology — Payments: $4,458
Dermatology $4,458
Ingrid Freeny, M.d, M.D
Dermatology — Payments: $4,391
Dermatology $4,391
Ghazel Waiz, Pa-C, PA-C
Dermatology — Payments: $2,525
Dermatology $2,525
Dr. Jason Mcbean, M.d, M.D
Dermatology — Payments: $1,823
Dermatology $1,823
Yesul Kim, Md, MD
Dermatology — Payments: $784.60
Dermatology $784.60